3//SEC Filing
UPMC 3
Accession 0000899243-21-017375
CIK 0001785530other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:46 PM ET
Size
5.8 KB
Accession
0000899243-21-017375
Insider Transaction Report
Form 3
UPMC
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (823,945 underlying)Series B Preferred Stock
→ Common Stock (273,811 underlying)
Footnotes (2)
- [F1]The Series A Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F2]The Series B Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
IncorporatedPA
Related Parties
1- filerCIK 0001644244
Filing Metadata
- Form type
- 3
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 4:46 PM ET
- Size
- 5.8 KB